Association between the soluble epoxide hydrolase gene and preeclampsia

Objective: In this study the association between K55R polymorphism, methylation level of the EPHX2 promoter region, and PE was investigated in 520 individuals including 260 PE patients and 260 healthy pregnant women. Methods: K55R polymorphism and methylation level of the EPHX2 promoter were determi...

Full description

Bibliographic Details
Published in:	Hypertension in Pregnancy
Main Authors:	Ismail Sari, Hatice Pinarbasi, Ergun Pinarbasi, Caglar Yildiz
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-10-01
Subjects:	soluble epoxide hydrolase genetic polymorphism epoxyeicosatrienoic acid methylation
Online Access:	http://dx.doi.org/10.1080/10641955.2017.1388390

Similar Items

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
by: Sarı İsmail, et al.
Published: (2020-01-01)

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
by: Matthieu Leuillier, et al.
Published: (2023-02-01)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019-01-01)

Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
by: Shuo Wang, et al.
Published: (2025-04-01)

Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches
by: Peng Gao, et al.
Published: (2024-02-01)

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain
by: Sandra Codony, et al.
Published: (2025-12-01)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
by: Shan Jiang, et al.
Published: (2024-04-01)

The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023-02-01)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
by: Rebecca Charles, et al.
Published: (2022-06-01)

Role of soluble epoxide hydrolase in pain and depression comorbidity
by: Yuchen Bu, et al.
Published: (2024-04-01)

Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
by: Biswajit Kundu, et al.
Published: (2024-06-01)

Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
by: Věra Čertíková Chábová, et al.
Published: (2018-03-01)

Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
by: An Huang, et al.
Published: (2018-10-01)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
by: Fangyu Du, et al.
Published: (2022-03-01)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
by: Juan Martín-López, et al.
Published: (2021-12-01)

Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides
by: Jiamin Dang, et al.
Published: (2022-11-01)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
by: Jang Hoon Kim, et al.
Published: (2022-09-01)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
by: Michelle Flores Domingues, et al.
Published: (2020-01-01)

Screening, Identification and Mechanism of Action of Cod-Derived Soluble Epoxide Hydrolase Inhibitory Peptides Based on Pharmacophore Model
by: LIU Pan, TU Maolin, LIU Hanxiong, CHENG Shuzhen, XU Xianbing, DU Ming
Published: (2023-03-01)

Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina
by: Jang Hoon Kim, et al.
Published: (2015-12-01)

Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts
by: Juanjuan Li, et al.
Published: (2024-11-01)

ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways
by: Jun-xia Jiang, et al.
Published: (2020-01-01)

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
by: Thomas Duflot, et al.
Published: (2019-03-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)

Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury
by: Li-Ping Liu, et al.
Published: (2018-04-01)

Inhibition of soluble epoxide hydrolase in endotoxin induced pig lung injury
by: Niklas Larsson, et al.
Published: (2025-09-01)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01)

Inhibitory activity of lignanamides isolated from hemp seed hulls(Cannabis sativa L.) against soluble epoxide hydrolase
by: Jang Hoon Kim, et al.
Published: (2023-09-01)

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
by: Chun-Hu Wu, et al.
Published: (2017-11-01)

In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design
by: Shuvam Sar, et al.
Published: (2023-08-01)

In Vitro and In Silico Studies of Soluble Epoxide Hydrolase Inhibitors from the Roots of <i>Lycopus lucidus</i>
by: Yoo Kyong Han, et al.
Published: (2021-02-01)

Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
by: Chia-Chi Hung, et al.
Published: (2019-06-01)

Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development
by: Cindy B. McReynolds, et al.
Published: (2021-08-01)

Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase
by: Cai Yi Wang, et al.
Published: (2019-01-01)

Adamantane Analogs: From Anti-Influenza Drugs to Soluble Epoxide Hydrolase Inhibitors for Acute Pancreatitis
by: Santiago Vázquez
Published: (2019-08-01)

Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway
by: Yue Yu, et al.
Published: (2023-11-01)

Isolation of Two New Compounds and Other Constituents from Leaves of <i>Piper crocatum</i> and Study of Their Soluble Epoxide Hydrolase Activities
by: Hong Xu Li, et al.
Published: (2019-01-01)

Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
by: Karen M. Wagner, et al.
Published: (2021-12-01)

Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke
by: Di Yu, et al.
Published: (2023-01-01)